Neural Analytics, Inc. announced on 5/30/18 that it received FDA 510(k) clearance for its NeuralBot System, a robotic assistance technology which automatically adjusts orientation and position of... read more
Neural Analytics, Inc. announced on 5/30/18 that it received FDA 510(k) clearance for its NeuralBot System, a robotic assistance technology which automatically adjusts orientation and position of... read more
Researchers from The Sport Science Center at Texas Christian University, Texas Health Sports Medicine, and the University of Wisconsin–La Crosse evaluated the usefulness of biomarker testing in... read more
Pfizer Inc. (NYSE:PFE) announced on 5/29/18 that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Xalkori (crizotinib) for the treatment of patients with... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,